Matches in Wikidata for { <http://www.wikidata.org/entity/Q63811665> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q63811665 description "clinical trial" @default.
- Q63811665 description "ensayu clínicu" @default.
- Q63811665 description "klinisch onderzoek" @default.
- Q63811665 description "клінічне випробування" @default.
- Q63811665 name "A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)" @default.
- Q63811665 type Item @default.
- Q63811665 label "A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)" @default.
- Q63811665 prefLabel "A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)" @default.
- Q63811665 P1050 Q63811665-B363586D-CA66-4F97-8EE5-EB40E91FCEAD @default.
- Q63811665 P1132 Q63811665-98DD227F-393D-4633-A516-DA3F9585FF94 @default.
- Q63811665 P1476 Q63811665-BAFF3B85-5E7C-454A-9B00-8B7C38D78D38 @default.
- Q63811665 P17 Q63811665-F7704E4D-0823-49C4-8562-02AFE9EF6DDD @default.
- Q63811665 P1813 Q63811665-C110A03C-6531-4272-9C68-836E7FCBBBE0 @default.
- Q63811665 P2899 Q63811665-7CF882C0-DEB0-4F77-812B-1C01F83EB37F @default.
- Q63811665 P3098 Q63811665-B987AFD1-C3E4-4F08-8BC9-512C6D642CED @default.
- Q63811665 P31 Q63811665-8F0F4A88-5DA2-419D-84E7-70296ED78C8D @default.
- Q63811665 P4844 Q63811665-02F25642-B8DF-4CA9-A4EE-D43E42E2D9F6 @default.
- Q63811665 P580 Q63811665-79950EF8-DC19-497C-A01E-86A44BE3B68E @default.
- Q63811665 P582 Q63811665-9B0F728A-A28B-476C-84B0-61A067830FA0 @default.
- Q63811665 P6099 Q63811665-1625F870-7AAB-4DB3-AFCA-9CBD0E3F2504 @default.
- Q63811665 P6153 Q63811665-04F1FCD0-9881-41CE-B188-4A68CD913FDB @default.
- Q63811665 P6153 Q63811665-810907CC-20E2-4411-96F5-077DE82E842A @default.
- Q63811665 P6153 Q63811665-913BA425-7AF2-48CD-8A23-34A94D6A1D89 @default.
- Q63811665 P6153 Q63811665-9FA484FD-B2E1-4221-8169-37B68F251929 @default.
- Q63811665 P6153 Q63811665-A6706F54-6AC0-4E52-9D62-EBB4A18B934A @default.
- Q63811665 P6153 Q63811665-AC30A439-3250-46EA-AE7A-65E8D97880EA @default.
- Q63811665 P6153 Q63811665-BD12BE97-3C3A-4766-BACF-5406751A3DFB @default.
- Q63811665 P6153 Q63811665-E9476714-AC26-4377-A600-760E47F4F824 @default.
- Q63811665 P6153 Q63811665-F2B0FE4D-F384-44A6-A316-359D308C91D4 @default.
- Q63811665 P6153 Q63811665-FA7010E7-EAC0-46E4-8EE6-CD3EE6953F9D @default.
- Q63811665 P8363 Q63811665-155DC9A8-A1D9-43CA-8825-8DC8D180422E @default.
- Q63811665 P859 Q63811665-7B1C6D68-C7CA-4AAB-BBFC-AE47AA0C252F @default.
- Q63811665 P1050 Q27429789 @default.
- Q63811665 P1132 "+360" @default.
- Q63811665 P1476 "Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-Comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration" @default.
- Q63811665 P17 Q30 @default.
- Q63811665 P1813 "Archway" @default.
- Q63811665 P2899 "+50" @default.
- Q63811665 P3098 "NCT03677934" @default.
- Q63811665 P31 Q30612 @default.
- Q63811665 P4844 Q414270 @default.
- Q63811665 P580 "2018-09-12T00:00:00Z" @default.
- Q63811665 P582 "2021-02-28T00:00:00Z" @default.
- Q63811665 P6099 Q42824827 @default.
- Q63811665 P6153 Q153265 @default.
- Q63811665 P6153 Q30269573 @default.
- Q63811665 P6153 Q30270222 @default.
- Q63811665 P6153 Q30270224 @default.
- Q63811665 P6153 Q30270282 @default.
- Q63811665 P6153 Q30270399 @default.
- Q63811665 P6153 Q30284006 @default.
- Q63811665 P6153 Q30296372 @default.
- Q63811665 P6153 Q50039597 @default.
- Q63811665 P6153 Q50039608 @default.
- Q63811665 P8363 Q78089383 @default.
- Q63811665 P859 Q212646 @default.